Citation: E. Kivisaari et al., Comparison of once daily fluticasone propionate aqueous nasal spray with once daily budesonide reservoir powder device in patients with perennial rhinitis, CLIN EXP AL, 31(6), 2001, pp. 855-863
Authors:
Lundback, B
Jenkins, C
Price, MJ
Thwaites, RMA
Citation: B. Lundback et al., Cost-effectiveness of salmeterol/fluticasone propionate combination product 50/250 mu g twice daily and budesonide 800 mu g twice daily in the treatment of adults and adolescents with asthma, RESP MED, 94(7), 2000, pp. 724-732
Citation: Gk. Scadding et al., Patient and physician perspectives on the impact and management of perennial and seasonal allergic rhinitis, CLIN OTOLAR, 25(6), 2000, pp. 551-557
Citation: Pm. Smith et Mj. Price, Physiological effects of variations in spontaneously chosen crank rate during submaximal and supramaximal upper body exercise. Int J Sports Med 1999;19 : 239-245 re: Marais G, Weissland T, Robin H, Vanvelcenaher JM, Lavoie JM, Pelayo P, INT J SP M, 21(7), 2000, pp. 540-541
Authors:
Stempel, DA
Stanford, RH
Thwaites, RMA
Price, MJ
Citation: Da. Stempel et al., Cost-efficacy comparison of inhaled fluticasone propionate and budesonide in the treatment of asthma, CLIN THER, 22(12), 2000, pp. 1562-1574
Authors:
Patel, R
Tyring, S
Strand, A
Price, MJ
Grant, DM
Citation: R. Patel et al., Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection, SEX TRANS I, 75(6), 1999, pp. 398-402
Citation: Mj. Price et Ig. Campbell, Thermoregulatory responses of spinal cord injured and able-bodied athletesto prolonged upper body exercise and recovery, SPINAL CORD, 37(11), 1999, pp. 772-779
Authors:
Lundback, B
Pieters, WR
Johansson, G
Palmqvist, M
Price, MJ
Sondhi, S
Thwaites, RMA
Citation: B. Lundback et al., Cost-effectiveness analyses of salmeterol/fluticasone propionate combination product and fluticasone propionate in patients with asthma I: Introduction and overview, PHARMACOECO, 16, 1999, pp. 1-8
Authors:
Pieters, WR
Lundback, B
Johansson, G
Palmqvist, M
Price, MJ
Sondhi, S
Thwaites, RMA
Yan, SK
Citation: Wr. Pieters et al., Cost-effectiveness analyses of salmeterol/fluticasone propionate combination product and fluticasone propionate in patients with asthma II: Study methodologies, PHARMACOECO, 16, 1999, pp. 9-14
Citation: G. Johansson et al., Cost-effectiveness analysis of salmeterol/fluticasone propionate 50/100 mug vs fluticasone propionate 100 mu g in adults and adolescents with asthmaIII: Results, PHARMACOECO, 16, 1999, pp. 15-21
Citation: M. Palmqvist et al., Cost-effectiveness analysis of salmeterol/fluticasone propionate 50/250 mug vs fluticasone propionate 250 mu g in adults and adolescents with asthmaIV: Results, PHARMACOECO, 16, 1999, pp. 23-28
Authors:
Pieters, WR
Lundback, B
Sondhi, S
Price, MJ
Thwaites, RMA
Citation: Wr. Pieters et al., Cost-effectiveness analysis of salmeterol/fluticasone propionate 50/500 mug vs fluticasone propionate 500 mu g in patients with corticosteroid-dependent asthma V: Results, PHARMACOECO, 16, 1999, pp. 29-34
Citation: Nc. Barnes et al., The cost-effectiveness of inhaled fluticasone propionate and budesonide inthe treatment of asthma in adults and children, RESP MED, 93(6), 1999, pp. 402-407
Citation: Mj. Price et Ig. Campbell, Thermoregulatory and physiological responses of wheelchair athletes to prolonged arm crank and wheelchair exercise, INT J SP M, 20(7), 1999, pp. 457-463